Akebia Therapeutics, Inc.·4

Jan 22, 4:06 PM ET

FRIESON RON 4

4 · Akebia Therapeutics, Inc. · Filed Jan 22, 2025

Insider Transaction Report

Form 4
Period: 2025-01-17
FRIESON RON
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2025-01-17$0.45/sh+20,100$9,04593,800 total
  • Exercise/Conversion

    Stock Option (Right to buy)

    2025-01-1720,1000 total
    Exercise: $0.45From: 2023-06-08Exp: 2032-06-08Common Stock (20,100 underlying)

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT